Burton Paul Drayer, MD, is the Charles M. and Marilyn Newman Professor and System Chair of the Department of Radiology for The Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai as well as the CEO of the Mount Sinai Doctors Faculty Practice and Dean for Clinical Affairs. He previously served as the President of The Mount Sinai Hospital from November 2003 to September 2008.
Dr. Drayer’s academic appointments began in 1977 as Associate Professor of Radiology at the University of Pittsburgh Health Center. From 1979 to 1986, Dr. Drayer was faculty at Duke University Medical Center where he became Professor of Radiology and Assistant Professor of Medicine (Neurology). He is Board Certified in both Radiology/Neuroradiology and Neurology. In 1986, he was appointed Chair of the Division of Neuroimaging Research-Education at the Barrow Neurological Institute in Phoenix Arizona where he remained until 1995 and also became Chair of Radiology at St. Joseph’s Hospital. In 1995, Dr. Drayer moved to his present Radiology position at the Mount Sinai Medical Center.
Internationally known for his research using anatomic, physiologic, and functional imaging of the aging brain, brain iron (the first to define the normal and abnormal presence of iron using MRI), neurodegenerative disorders, brain infarction, xenon enhanced CT for measuring regional cerebral blood flow (first described its potential, feasibility, and application), MR angiography, multiple sclerosis, and intrathecal contrast media toxicity, Dr. Drayer has over 200 publication in major journals as well as multiple book chapters. He has been on many editorial boards and was Editor of Neuroimaging Clinics of North America from 1990 to 2005. He is also well recognized as an expert in the development of outpatient imaging facilities, imaging center design, and advanced imaging equipment. Dr. Drayer also serves on the Board of Directors of Hospitals Insurance Company (HIC), a malpractice liability insurance captive.
Dr. Drayer has been a leader in the major national and international Radiology societies. He was on the Board of Directors of the American Society of Neuroradiology (ASNR) from 1990 to 2000 and was ASNR President (1996-1997). He was also a founding member and the inaugural Chairman of the Research Foundation of the ASNR (1995-2001). He was on the Board of Directors of the Radiological Society of North America (RSNA) as the Liaison for the Annual Meeting and IT from 2003 to 2008, Chairman of the Board in 2009, and President Elect and President in 2010 and 2011. He was Chairman of the RSNA Research and Education Foundation from 2015-2016. Additionally, Dr. Drayer was on the Board of Chancellors of the American College of Radiology (ACR) from 2009-2015 and Chaired the ACR Panel on Neurologic Imaging Appropriateness Criteria from 1994-2003. He also served on the Board of Directors of the Academy of Radiology Research (ARR) from 1995 to 2000 and 2009 to 2012.
Among the honors presented to Dr. Drayer were the ASNR Cornelius Dyke (1977) and Outstanding Paper (1978, 1981) awards, the Jacobi Medallion of the Mount Sinai Medical Center (2009), honorary fellowship in the Royal College of Surgeons, Ireland (2011), honorary member of the European Society of Radiology (2012), and the Gold Medal of the ASNR in 2011 and the RSNA in 2016. Dr. Drayer is a fellow of both the American Academy of Neurology and the American College of Radiology. His career has been dedicated to enhancing the educational, clinical, research , and administrative platform for his associates at Mount Sinai as well as the national and international community of radiologists and imaging scientists.
Neurology, American Board of Psychiatry and Neurology
MD, Chicago Medical School
Internship, Internal Medicine
Medical Center Hospital of Vermont
Medical Center Hospital of Vermont
Residency, Diagnostic Radiology
University of Pittsburgh
University of Pittsburgh Medical Center
English, Hebrew, Spanish
Chairman, Radiological Society of North America
Research and Education Foundation
Board of Chancellors
American College of Radiology
European Society of Radiology
Radiological Society of North America
The Royal College of Surgeons (Ireland)
Gold Medal Award
American Society of Neuroradiology
New York Magazine
Mount Sinai Medical Center
Distinguished Service Award
American Board of Radiology
Dr. Charles M. and Marilyn Newman Professor of Radiology
Distinguished Alumnus Award
Chicago Medical School
Cornelius G. Dyke Award
American Society of Neuroradiology
First Prize President's Award
Pittsburgh Roentgen Ray Society
• CT Scanning
• MRI (anatomic and functional)
• Cerebral Infarction
• Neurodenerative Disease and Normal Aging
• Vascular Malformation of the Brain
• Parkinson's Disease
• Alzheimer's Disease
• Multiple Sclerosis
• Brain Neoplasms
• Brain Iron on MRI
• Regional Cerebral Blood Flow (Xenon CT)
• Intrathecal Contrast-Mechanism of Adverse reactions
• CSF Circulation
• Magnetic Resonance Angiography (MRA)
• PET Scanning-Radiation Necrosis vs. Glioma
• Blood Brain Barrier Integrity
• Imaging Non-human Primate Models
Drayer BP. Peggy J. Fritzsche, MD, President Radiological Society of North America, 2003. Radiology 2003 Jan; 226(1).
Fatterpekar GM, Naidich TP, Delman BN, Aguinaldo JG, Gultekin SH, Sherwood CC, Hof PR, Drayer BP, Fayad ZA. Cytoarchitecture of the human cerebral cortex: MR microscopy of excised specimens at 9.4 Tesla. AJNR. American journal of neuroradiology 2002 Sep; 23(8).
Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, Kaufmann H. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Archives of neurology 2002 May; 59(5).
Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. Journal of the American College of Cardiology 2002 Apr; 39(8).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Drayer did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.